[EN] THIAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE<br/>[FR] DÉRIVÉS DE THIAZINE EN TANT QU'INHIBITEURS DE BÊTA-SÉCRÉTASE ET PROCÉDÉS D'UTILISATION
申请人:AMGEN INC
公开号:WO2018112083A1
公开(公告)日:2018-06-21
The present disclosure provides a class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula I: (see Formula I structure) wherein variables R1, R1', R2, R2', R3, R4, R5, R6, R7, and b of Formula I are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, and uses of the compounds and compositions for treatment of disorders and/or conditions related to Aβ plaque formation and deposition, resulting from the biological activity of BACE. Such BACE mediated disorders include, for example, Alzheimer's Disease, cognitive deficits, cognitive impairments, and other central nervous system conditions.
本公开提供了一类化合物,用于调节β-分泌酶酶(BACE)的活性。这些化合物具有一般的化学式 I:(参见化学式 I 结构),其中化学式 I 中的变量 R1、R1'、R2、R2'、R3、R4、R5、R6、R7 和 b 在此处定义。本公开还提供了包括这些化合物的药物组合物,以及这些化合物和组合物用于治疗与Aβ斑块形成和沉积相关的疾病和/或症状的用途,这些疾病和症状是由于BACE的生物活性而导致的。这类由BACE介导的疾病包括阿尔茨海默病、认知缺陷、认知障碍和其他中枢神经系统疾病。